Catalan biotech Mind the Byte enters Japanese market; €1.2 million annual turnover expected by 2020
Mind the Byte, a Catalan company dedicated to computational drug design, will enter the bioinformatics market in Japan, thanks to a distribution agreement with the Japanese company Filgen. This agreement came after several meetings between the companies during a mission of the public business competitiveness and internationalisation agency ACCIÓ in Japan last year. The founder and CEO of Mind the Byte, Alfons Nonell-Canals, stated that this step is important as the overall bioinformatics market in Japan “is expected to grow 21% by 2020”. The company estimates that it will have an annual turnover of €1.2 million in Japan by 2020, “a very large and mature market in the field of biotechnology”. "We are small and we are in a phase of development but Japan is a key country", said Nonell-Canals.